Concepedia

Xueli Fu

XF

Statistics

Publications

5

Citations

295

H-Index

5

Active since

2019

Affiliations

State Key Laboratory of Medicinal Chemical Biology(Current)

Nankai University

Xueli Fu is an author at State Key Laboratory of Medicinal Chemical Biology specializing in tumor biology, cell biology, and medicine.

Top concepts

Publications per year

2019–2022

5

Publications

5

Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma

Tianjiao Wang, Xueli Fu, Tianzhi Jin et al. · EBioMedicine · 2019 · 137 citations · Full text

Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma

Lu Zhang, Xian-meng Li, Xu-he Shi et al. · Acta Pharmacologica Sinica · 2022 · 79 citations · Full text

, , +18

The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt–PCAF pathway in promotion of esophageal squamous cell carcinoma growth

Yue Wu, Xue Wang, Feifei Xu et al. · Nucleic Acids Research · 2020 · 46 citations · Full text

, , +18

The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth

Feifei Xu, Huimin Sun, Runping Fang et al. · Acta Pharmacologica Sinica · 2021 · 21 citations · Full text

, , +10

HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis

Lu Zhang, Xiaolei Zhou, Bowen Liu et al. · Acta Pharmaceutica Sinica B · 2022 · 12 citations · Full text

Rows per page

1–5 of 5